Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Objective home-based EEG prediction of aMCI: Identification of a predictive electrophysiological model of cognitive function in amnesic mild cognitive impairment.

Project description

A prediction model of dementia

Dementia refers to an age-related group of progressive brain disorders such as Alzheimer's disease (AD) that affect millions of adults in Europe. AD is usually preceded by amnestic mild cognitive impairment (aMCI), which is characterised by reduced memory skills. Being able to diagnose and characterise aMCI promptly would facilitate the delivery of early interventions, thereby delaying AD onset. Scientists of the EU-funded ID-earlyMCI project propose to use electroencephalography (EEG) alongside behavioural practices to measure brain activity in patients and develop a predictive model of cognitive function. Advanced machine learning methods will be used on a large EEG database, contributing to improved healthcare services for patients with aMCI.

Objective

Dementia is an umbrella term for age-related brain disease, of which Alzheimer’s Disease (AD) is the most common. Around 5-7% of adults over 60 years suffer dementia worldwide, with approx. 8.7 m people in the EU. A frequent precursor of AD is amnestic mild cognitive impairment (aMCI), a clinical condition characterised by declines in memory skills. By predicting
aMCI progression, health-care services will have new opportunities to deliver early interventions that could delay AD onset. This will ultimately promote functional independence in vulnerable adults and meet the societal challenge Health, Demographic Change and Wellbeing of Horizon 2020.

Clinical outcomes of aMCI patients are influenced by the severity of cognitive (dys-) function. However, these deficits may occur at an advanced stage of neurodegeneration. This fellowship aims to identify a predictive model of cognitive function based on brain activity measured with electro-encephalography (EEG). Previous studies suggest that the capacity to learn a new task (practice effects) can help classify a person into healthy, aMCI or AD. Also, cross-sectional studies using EEG have found differences between normal controls, aMCI and AD patients during rest and cognitive tasks. The behavioural and EEG evidence combined shows the potential of using behavioural practice and EEG measures to predict cognitive function.

This potential will be investigated and exploited in this fellowship via advanced machine learning methods on a large EEG
data sample. This fellowship will take place in BrainWaveBank (BWB), an innovative company developing the largest database of EEG data in older adults along with cutting-edge analytics. This fellowship will allow the researcher to apply her experience on neural engineering and expand her knowledge and expertise to machine learning and clinical neuroscience in BWB. This will build the researcher’s independence and build prospects for a career in the medical technology sector.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2019

See all projects funded under this call

Coordinator

BRAINWAVEBANK LTD.
Net EU contribution
€ 184 590,72
Address
THE INNOVATION CENTRE, UNIT 4, QUEE
BT39DT BELFAST
United Kingdom
SME
Yes
Region
Northern Ireland Northern Ireland Belfast
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 184 590,72